Invesco S&P Emerging Markets Low Volatility Index ETF (TSE:ELV – Get Free Report) was upgraded by stock analysts at Raymond James to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.
Separately, Alliance Global Partners raised shares of Invesco S&P Emerging Markets Low Volatility Index ETF to a “strong-buy” rating in a research note on Thursday, September 26th.
Read Our Latest Research Report on Invesco S&P Emerging Markets Low Volatility Index ETF
Invesco S&P Emerging Markets Low Volatility Index ETF Stock Performance
Invesco S&P Emerging Markets Low Volatility Index ETF Company Profile
Elevance Health Inc operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
Read More
- Five stocks we like better than Invesco S&P Emerging Markets Low Volatility Index ETF
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Braskem: A Green Investment in the Bioplastics Market
- Profitably Trade Stocks at 52-Week Highs
- Got 1K to Invest? These 3 Stocks Are Still Magnificent Buys
- Airline Stocks – Top Airline Stocks to Buy Now
- Abbott Laboratories Will Outperform Healthcare Stocks in 2025
Receive News & Ratings for Invesco S&P Emerging Markets Low Volatility Index ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco S&P Emerging Markets Low Volatility Index ETF and related companies with MarketBeat.com's FREE daily email newsletter.